Xenon Pharmaceuticals Inc header image

Xenon Pharmaceuticals Inc

XENE

Equity

ISIN null / Valor 25419823

NASDAQ (2026-07-02)

USD 60.96+1.09%

Xenon Pharmaceuticals Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Xenon Pharmaceuticals Inc is a biopharmaceutical company dedicated to the discovery and development of novel small molecule therapies targeting neurological and central nervous system disorders. The company focuses on advancing treatments for conditions such as epilepsy and dystonia, utilizing its proprietary drug discovery platforms to move candidates through clinical development stages. Operating primarily in the United States, Canada, and the European Union, Xenon Pharmaceuticals aims to address unmet medical needs by delivering innovative therapeutic solutions within the neurological space.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

82.7%1Y

58.3%3Y

230%5Y

Performance

52.3%1Y

45.7%3Y

57.6%5Y

Volatility

5893 M

Market cap (USD)

1,462,554

Daily traded volume (Shares)

38.78 / 38.23

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Gyre Therapeutics Inc

Gyre Therapeutics Inc Valor: 130270397

Annual Return

-50%0%+50%

Risk level

110

12.58%USD 7.34

Emcure Pharmaceuticals Limited

Emcure Pharmaceuticals Limited Valor: 136422285

Annual Return

-50%0%+50%

Risk level

110

-0.94%INR 1,837.10

HCA Healthcare Inc

HCA Healthcare Inc Valor: 11321027

Annual Return

-50%0%+50%

Risk level

110

4.39%USD 410.50

Ironwood Pharmaceuticals Inc

Ironwood Pharmaceuticals Inc Valor: 10773079

Annual Return

-50%0%+50%

Risk level

110

5.10%USD 4.33

Tilray Brands Inc

Tilray Brands Inc Valor: 42386407

Annual Return

-50%0%+50%

Risk level

110

4.29%USD 4.62

H. Lundbeck A/S

H. Lundbeck A/S Valor: 119252587

Annual Return

-50%0%+50%

Risk level

110

-2.66%DKK 43.12

Rubicon Research Limited

Rubicon Research Limited Valor: 149582844

Annual Return

-50%0%+50%

Risk level

110

-5.22%INR 1,302.75

BridgeBio Pharma Inc

BridgeBio Pharma Inc Valor: 48204826

Annual Return

-50%0%+50%

Risk level

110

3.58%USD 77.19

Dr. Lal PathLabs Limited

Dr. Lal PathLabs Limited Valor: 30691066

Annual Return

-50%0%+50%

Risk level

110

-0.37%INR 1,646.15

Robertet SA

Robertet SA Valor: 510354

Annual Return

-50%0%+50%

Risk level

110

0.24%EUR 820.00

SIX

FactSet

Clearbit

Logos provided by Clearbit